US Patent 7700654 Isolation of
Patent 7700654 was granted and assigned to LTS Lohmann Therapie-Systeme AG on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+529 characters)
Article
Patent abstract
A process for isolating N-butylbenzenesulfonamide (NBBS) from biological material, the chemical synthesis of benzenesulfonamide derivatives, the use of NBBS and benzenesulfonamide derivatives for treating benign prostatic hyperplasia and/or prostate carcinoma, the production of medicaments for the treatment thereof, and the use of NBBS and benzenesulfonamide derivatives as a lead substance in the development of active substances for treating benign prostatic hyperplasia and/or prostate carcinoma are provided.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Aria Baniahmad0
Hans-Rainer Hoffmann0
Rudolf Matusch0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07700654 Isolation of US Patent 7700654 Isolation of
Infobox
Patent Number
077006540
Patent Number
77006540
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077006540
Date of Patent
April 20, 2010
0Patent Application Number
118834150
Date Filed
January 28, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07700654 Isolation of
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07700654
Date of patent
April 20, 2010
Patent application number
11883415
Date Filed
January 28, 2006
Patent primary examiner
Find more entities like US Patent 7700654 Isolation of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.